For example, the presence of laryngeal cancer stem cells that overexpress KRAS, HIF-1α, and VEGF-A is associated with increased resistance of HNSCC to Cetuximab [171]. The gene discussed is VEGFA; the disease is head and neck squamous cell carcinoma.